Dhillon Jaydeep, Kraeutler Matthew J, Fasulo Sydney M, Belk John W, Mulcahey Mary K, Scillia Anthony J, McCulloch Patrick C
Rocky Vista University College of Osteopathic Medicine, Parker, Colorado, USA.
Department of Orthopedics & Sports Medicine, Houston Methodist Hospital, Houston, Texas, USA.
Orthop J Sports Med. 2023 Mar 20;11(3):23259671231151707. doi: 10.1177/23259671231151707. eCollection 2023 Mar.
The extent to which concomitant osteotomy provides an improvement in clinical outcomes after cartilage repair procedures is unclear.
To review the existing literature to compare clinical outcomes of patients undergoing cartilage repair of the tibiofemoral joint with versus without concomitant osteotomy.
Systematic review; Level of evidence, 4.
A systematic review was conducted according to the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines by searching PubMed, the Cochrane Library, and Embase to identify studies that directly compared outcomes between cartilage repair of the tibiofemoral joint alone (group A) versus cartilage repair with concomitant osteotomy (high tibial osteotomy [HTO] or distal femoral osteotomy [DFO]) (group B). Studies on cartilage repair of the patellofemoral joint were excluded. The search terms used were as follows: osteotomy AND knee AND ("autologous chondrocyte" OR "osteochondral autograft" OR "osteochondral allograft" OR microfracture). Outcomes in groups A and B were compared based on reoperation rate, complication rate, procedure payments, and patient-reported outcomes (Knee injury and Osteoarthritis Outcome Score [KOOS], visual analog scale [VAS] for pain, satisfaction, and WOMAC).
Included in the review were 5 studies (1 level 2 study, 2 level 3 studies, 2 level 4 studies) with 1747 patients in group A and 520 patients in group B. The mean patient ages were 34.7 and 37.5 years in groups A and B, respectively, and the mean lesion sizes were 4.0 and 4.5 cm, respectively. The mean follow-up time was 44.6 months. The most common lesion location was the medial femoral condyle (n = 999). Preoperative alignment averaged 1.8° and 5.5° of varus in groups A and B, respectively. One study found significant differences between groups in KOOS, VAS, and satisfaction, favoring group B. The reoperation rates were 47.4% and 17.3% in groups A and B, respectively ( < .0001).
Patients undergoing cartilage repair of the tibiofemoral joint with concomitant osteotomy might be expected to experience greater improvement in clinical outcomes with a lower reoperation rate compared with those undergoing cartilage repair alone. Surgeons preparing for cartilage procedures of the knee joint should pay particular attention to preoperative malalignment of the lower extremity to optimize outcomes.
在软骨修复手术后,同期截骨术在多大程度上能改善临床疗效尚不清楚。
回顾现有文献,比较接受与未接受同期截骨术的胫股关节软骨修复患者的临床疗效。
系统评价;证据等级,4级。
根据PRISMA(系统评价和Meta分析的首选报告项目)指南进行系统评价,通过检索PubMed、Cochrane图书馆和Embase,以确定直接比较单纯胫股关节软骨修复(A组)与同期截骨术(高位胫骨截骨术[HTO]或股骨远端截骨术[DFO])的软骨修复(B组)之间疗效的研究。排除有关髌股关节软骨修复的研究。使用的检索词如下:截骨术、膝关节以及(“自体软骨细胞”或“骨软骨自体移植”或“骨软骨异体移植”或微骨折)。根据再次手术率、并发症发生率、手术费用以及患者报告的结局(膝关节损伤和骨关节炎结局评分[KOOS]、疼痛视觉模拟量表[VAS]、满意度和WOMAC)对A组和B组的结局进行比较。
纳入该评价的有5项研究(1项2级研究、2项3级研究、2项4级研究),A组有1747例患者,B组有520例患者。A组和B组患者的平均年龄分别为34.7岁和37.5岁,平均病变大小分别为4.0 cm和4.5 cm。平均随访时间为44.6个月。最常见的病变部位是股骨内侧髁(n = 999)。A组和B组术前内翻平均分别为1.8°和5.5°。一项研究发现两组在KOOS、VAS和满意度方面存在显著差异,B组更具优势。A组和B组的再次手术率分别为47.4%和17.3%(P < .0001)。
与单纯接受软骨修复的患者相比,接受同期截骨术的胫股关节软骨修复患者可能在临床疗效上有更大改善,再次手术率更低。准备进行膝关节软骨手术的外科医生应特别关注术前下肢的对线不良情况,以优化手术效果。